Viability of talus osteochondral defect cartilage for chondrocyte harvesting: Results of 151 patients

Christopher Kreulen, Eric Giza, Jason Kim, Valentina Campanelli, Martin Sullivan

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Large talar cartilage defects can be treated with either autologous chondrocyte implantation or matrix autologous chondrocyte implantation. Both techniques depend on successful harvesting of the chondrocytes. In the past, they have come from the ipsilateral knee, which has been associated with donor site morbidity. We hypothesized that damaged cartilage from the talus can be used as a reliable source for chondrocyte cell harvesting in preparation for possible matrix-induced autologous chondrocyte implantation (MACI). Methods: Chondrocytes were harvested from the injured talar cartilage during ankle arthroscopy and sent to a cell laboratory, measured for initial biopsy weight, cultured for 4 to 6 weeks, and then analyzed for viability. A total of 151 patients were analyzed. Results: The average biopsy initial weight was 187.1 mg. The average number of cells was 3.13 × 105. The viability of the chondrocytes provided by the manufacturer averaged 92.3% (range, 33%-100%). Conclusions: Chondrocytes harvested from the damaged talar articular cartilage were functional and proliferated with an average viability of 92%. Clinical Relevance: This technique may provide a useful source of chondrocytes if needed for a future cell-based regenerative procedure such as MACI while eliminating the need to harvest chondrocytes from the knee or other intact areas of cartilage on the talus.

Original languageEnglish (US)
Pages (from-to)341-345
Number of pages5
JournalFoot and Ankle International
Volume35
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Talus
Chondrocytes
Cartilage
Knee
Biopsy
Weights and Measures
Arthroscopy
Articular Cartilage
Ankle
Cell Count
Tissue Donors

Keywords

  • matrix-induced autologous chondrocyte implantation (MACI)
  • osteochondral defect
  • talar chondrocytes
  • talus

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine
  • Medicine(all)

Cite this

Viability of talus osteochondral defect cartilage for chondrocyte harvesting : Results of 151 patients. / Kreulen, Christopher; Giza, Eric; Kim, Jason; Campanelli, Valentina; Sullivan, Martin.

In: Foot and Ankle International, Vol. 35, No. 4, 2014, p. 341-345.

Research output: Contribution to journalArticle

@article{f8e0b449a53147ec82436b184785df95,
title = "Viability of talus osteochondral defect cartilage for chondrocyte harvesting: Results of 151 patients",
abstract = "Background: Large talar cartilage defects can be treated with either autologous chondrocyte implantation or matrix autologous chondrocyte implantation. Both techniques depend on successful harvesting of the chondrocytes. In the past, they have come from the ipsilateral knee, which has been associated with donor site morbidity. We hypothesized that damaged cartilage from the talus can be used as a reliable source for chondrocyte cell harvesting in preparation for possible matrix-induced autologous chondrocyte implantation (MACI). Methods: Chondrocytes were harvested from the injured talar cartilage during ankle arthroscopy and sent to a cell laboratory, measured for initial biopsy weight, cultured for 4 to 6 weeks, and then analyzed for viability. A total of 151 patients were analyzed. Results: The average biopsy initial weight was 187.1 mg. The average number of cells was 3.13 × 105. The viability of the chondrocytes provided by the manufacturer averaged 92.3{\%} (range, 33{\%}-100{\%}). Conclusions: Chondrocytes harvested from the damaged talar articular cartilage were functional and proliferated with an average viability of 92{\%}. Clinical Relevance: This technique may provide a useful source of chondrocytes if needed for a future cell-based regenerative procedure such as MACI while eliminating the need to harvest chondrocytes from the knee or other intact areas of cartilage on the talus.",
keywords = "matrix-induced autologous chondrocyte implantation (MACI), osteochondral defect, talar chondrocytes, talus",
author = "Christopher Kreulen and Eric Giza and Jason Kim and Valentina Campanelli and Martin Sullivan",
year = "2014",
doi = "10.1177/1071100714523272",
language = "English (US)",
volume = "35",
pages = "341--345",
journal = "Foot and Ankle International",
issn = "1071-1007",
publisher = "AOFAS - American Orthopaedic Foot and Ankle Society",
number = "4",

}

TY - JOUR

T1 - Viability of talus osteochondral defect cartilage for chondrocyte harvesting

T2 - Results of 151 patients

AU - Kreulen, Christopher

AU - Giza, Eric

AU - Kim, Jason

AU - Campanelli, Valentina

AU - Sullivan, Martin

PY - 2014

Y1 - 2014

N2 - Background: Large talar cartilage defects can be treated with either autologous chondrocyte implantation or matrix autologous chondrocyte implantation. Both techniques depend on successful harvesting of the chondrocytes. In the past, they have come from the ipsilateral knee, which has been associated with donor site morbidity. We hypothesized that damaged cartilage from the talus can be used as a reliable source for chondrocyte cell harvesting in preparation for possible matrix-induced autologous chondrocyte implantation (MACI). Methods: Chondrocytes were harvested from the injured talar cartilage during ankle arthroscopy and sent to a cell laboratory, measured for initial biopsy weight, cultured for 4 to 6 weeks, and then analyzed for viability. A total of 151 patients were analyzed. Results: The average biopsy initial weight was 187.1 mg. The average number of cells was 3.13 × 105. The viability of the chondrocytes provided by the manufacturer averaged 92.3% (range, 33%-100%). Conclusions: Chondrocytes harvested from the damaged talar articular cartilage were functional and proliferated with an average viability of 92%. Clinical Relevance: This technique may provide a useful source of chondrocytes if needed for a future cell-based regenerative procedure such as MACI while eliminating the need to harvest chondrocytes from the knee or other intact areas of cartilage on the talus.

AB - Background: Large talar cartilage defects can be treated with either autologous chondrocyte implantation or matrix autologous chondrocyte implantation. Both techniques depend on successful harvesting of the chondrocytes. In the past, they have come from the ipsilateral knee, which has been associated with donor site morbidity. We hypothesized that damaged cartilage from the talus can be used as a reliable source for chondrocyte cell harvesting in preparation for possible matrix-induced autologous chondrocyte implantation (MACI). Methods: Chondrocytes were harvested from the injured talar cartilage during ankle arthroscopy and sent to a cell laboratory, measured for initial biopsy weight, cultured for 4 to 6 weeks, and then analyzed for viability. A total of 151 patients were analyzed. Results: The average biopsy initial weight was 187.1 mg. The average number of cells was 3.13 × 105. The viability of the chondrocytes provided by the manufacturer averaged 92.3% (range, 33%-100%). Conclusions: Chondrocytes harvested from the damaged talar articular cartilage were functional and proliferated with an average viability of 92%. Clinical Relevance: This technique may provide a useful source of chondrocytes if needed for a future cell-based regenerative procedure such as MACI while eliminating the need to harvest chondrocytes from the knee or other intact areas of cartilage on the talus.

KW - matrix-induced autologous chondrocyte implantation (MACI)

KW - osteochondral defect

KW - talar chondrocytes

KW - talus

UR - http://www.scopus.com/inward/record.url?scp=84899019241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899019241&partnerID=8YFLogxK

U2 - 10.1177/1071100714523272

DO - 10.1177/1071100714523272

M3 - Article

C2 - 24513592

AN - SCOPUS:84899019241

VL - 35

SP - 341

EP - 345

JO - Foot and Ankle International

JF - Foot and Ankle International

SN - 1071-1007

IS - 4

ER -